CN100441597C - 抗b型流感病毒单克隆抗体及使用该抗体的免疫测定器具 - Google Patents
抗b型流感病毒单克隆抗体及使用该抗体的免疫测定器具 Download PDFInfo
- Publication number
- CN100441597C CN100441597C CNB2004800211308A CN200480021130A CN100441597C CN 100441597 C CN100441597 C CN 100441597C CN B2004800211308 A CNB2004800211308 A CN B2004800211308A CN 200480021130 A CN200480021130 A CN 200480021130A CN 100441597 C CN100441597 C CN 100441597C
- Authority
- CN
- China
- Prior art keywords
- type
- antibody
- influenza
- influenza virus
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003018 immunoassay Methods 0.000 title claims abstract description 32
- 241000713196 Influenza B virus Species 0.000 title abstract 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 55
- 102000011931 Nucleoproteins Human genes 0.000 claims abstract description 41
- 108010061100 Nucleoproteins Proteins 0.000 claims abstract description 41
- 241000712461 unidentified influenza virus Species 0.000 claims description 153
- 206010022000 influenza Diseases 0.000 claims description 83
- 239000011159 matrix material Substances 0.000 claims description 79
- 239000000427 antigen Substances 0.000 claims description 59
- 102000036639 antigens Human genes 0.000 claims description 59
- 108091007433 antigens Proteins 0.000 claims description 59
- 241000486679 Antitype Species 0.000 claims description 58
- 238000001514 detection method Methods 0.000 claims description 50
- 241000700605 Viruses Species 0.000 claims description 40
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108090000790 Enzymes Proteins 0.000 claims description 39
- 239000003153 chemical reaction reagent Substances 0.000 claims description 38
- 210000004408 hybridoma Anatomy 0.000 claims description 33
- 238000004321 preservation Methods 0.000 claims description 16
- 210000004027 cell Anatomy 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 13
- 239000003550 marker Substances 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 7
- 210000004881 tumor cell Anatomy 0.000 claims description 2
- 241000712431 Influenza A virus Species 0.000 abstract 1
- 241001500350 Influenzavirus B Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 70
- 238000000034 method Methods 0.000 description 46
- 229940088598 enzyme Drugs 0.000 description 36
- 239000007788 liquid Substances 0.000 description 30
- 238000012360 testing method Methods 0.000 description 20
- 239000012530 fluid Substances 0.000 description 15
- 238000002372 labelling Methods 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 229920000136 polysorbate Polymers 0.000 description 12
- 229960005486 vaccine Drugs 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 10
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 10
- 239000002250 absorbent Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
- 229940098773 bovine serum albumin Drugs 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 8
- 239000003513 alkali Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 230000002163 immunogen Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000000890 antigenic effect Effects 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 239000012228 culture supernatant Substances 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 230000008521 reorganization Effects 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 239000000123 paper Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000007790 solid phase Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 4
- 241000606153 Chlamydia trachomatis Species 0.000 description 4
- 241000606768 Haemophilus influenzae Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 241000186779 Listeria monocytogenes Species 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 241000193996 Streptococcus pyogenes Species 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 229940038705 chlamydia trachomatis Drugs 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 208000037797 influenza A Diseases 0.000 description 4
- 229940115931 listeria monocytogenes Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 201000000050 myeloid neoplasm Diseases 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 241001647372 Chlamydia pneumoniae Species 0.000 description 3
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 3
- 241000709687 Coxsackievirus Species 0.000 description 3
- 241001466953 Echovirus Species 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 3
- 241000991587 Enterovirus C Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101710154606 Hemagglutinin Proteins 0.000 description 3
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 3
- 241000711386 Mumps virus Species 0.000 description 3
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 3
- 102000005348 Neuraminidase Human genes 0.000 description 3
- 108010006232 Neuraminidase Proteins 0.000 description 3
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 3
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 3
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 101710176177 Protein A56 Proteins 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 241000607715 Serratia marcescens Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 102000005936 beta-Galactosidase Human genes 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000185 hemagglutinin Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940013390 mycoplasma pneumoniae Drugs 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 102000013415 peroxidase activity proteins Human genes 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- -1 polyoxyethylene Polymers 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 238000005354 coacervation Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 230000024835 cytogamy Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PVGATNRYUYNBHO-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-(2,5-dioxopyrrol-1-yl)butanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCN1C(=O)C=CC1=O PVGATNRYUYNBHO-UHFFFAOYSA-N 0.000 description 1
- WRBRCYPPGUCRHW-UHFFFAOYSA-N 2-iminobutanoic acid zwitterion Chemical compound CCC(=N)C(O)=O WRBRCYPPGUCRHW-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- UMTZYGZMIJRCFG-UHFFFAOYSA-N 3-phenyldioxetane Chemical compound C1OOC1C1=CC=CC=C1 UMTZYGZMIJRCFG-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- ARQXEQLMMNGFDU-UHFFFAOYSA-N 4MUG Natural products C1=CC=2C(C)=CC(=O)OC=2C=C1OC1OC(C(O)=O)C(O)C(O)C1O ARQXEQLMMNGFDU-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 201000005019 Chlamydia pneumonia Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101710121417 Envelope glycoprotein Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
- ZSEMWHCVIJETNE-UHFFFAOYSA-N N1=CC=CC2=CC(=C3C=CC=NC3=C12)S(=O)(=O)O.C(C)N1CSC2=C1C=CC=C2 Chemical compound N1=CC=CC2=CC(=C3C=CC=NC3=C12)S(=O)(=O)O.C(C)N1CSC2=C1C=CC=C2 ZSEMWHCVIJETNE-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000609499 Palicourea Species 0.000 description 1
- 241000845082 Panama Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- NEZJDVYDSZTRFS-YBXAARCKSA-N Phenylgalactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-YBXAARCKSA-N 0.000 description 1
- 206010035724 Pneumonia mycoplasmal Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- XYIPYISRNJUPBA-UHFFFAOYSA-N [3-(3'-methoxyspiro[adamantane-2,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC(C3)CC2C4)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 XYIPYISRNJUPBA-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- WOLHOYHSEKDWQH-UHFFFAOYSA-N amantadine hydrochloride Chemical compound [Cl-].C1C(C2)CC3CC2CC1([NH3+])C3 WOLHOYHSEKDWQH-UHFFFAOYSA-N 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N cyclobenzothiazole Natural products C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 208000030773 pneumonia caused by chlamydia Diseases 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012745 toughening agent Substances 0.000 description 1
- 238000010023 transfer printing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP278528/2003 | 2003-07-23 | ||
| JP2003278528 | 2003-07-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1826355A CN1826355A (zh) | 2006-08-30 |
| CN100441597C true CN100441597C (zh) | 2008-12-10 |
Family
ID=34074724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004800211308A Expired - Fee Related CN100441597C (zh) | 2003-07-23 | 2004-07-23 | 抗b型流感病毒单克隆抗体及使用该抗体的免疫测定器具 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPWO2005007698A1 (ru) |
| KR (1) | KR20060054333A (ru) |
| CN (1) | CN100441597C (ru) |
| HK (1) | HK1096975A1 (ru) |
| RU (1) | RU2366663C2 (ru) |
| WO (1) | WO2005007698A1 (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2309264A4 (en) | 2008-06-06 | 2011-11-23 | Univ Toyama Nat Univ Corp | FLU VIRUS DETECTION DEVICE |
| EP2418488B1 (en) * | 2009-04-09 | 2015-08-12 | ARKRAY, Inc. | Sample analyzing tool, method of manufacturing sample analyzing tool, and method of minimizing drop in solution permeability of deployment member |
| JP2010261912A (ja) * | 2009-05-11 | 2010-11-18 | Bl:Kk | ヒトインフルエンザウイルスｈ３亜型の免疫学的検出法 |
| JP5567932B2 (ja) * | 2010-08-03 | 2014-08-06 | 田中貴金属工業株式会社 | イムノクロマトグラフィー用試薬組成物およびそれを用いた測定方法 |
| RU2491338C2 (ru) * | 2011-06-30 | 2013-08-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский Институт гриппа" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ гриппа" Минздравсоцразвития России) | Применение моноклональных антител для идентификации ямагатской или викторианской эволюционных линий вируса гриппа типа в, штамм гибридомы 4н7 для получения моноклональных антител, предназначенных для определения вирусов гриппа в ямагатской ветви, штамм гибридомы в/4н1 для получения моноклональных антител, предназначенных для определения вирусов гриппа в викторианской ветви |
| TW201346040A (zh) | 2012-03-30 | 2013-11-16 | Tanaka Precious Metal Ind | 流行性感冒ａ型病毒檢驗用套組 |
| JP6182027B2 (ja) | 2013-09-10 | 2017-08-16 | デンカ生研株式会社 | Ｂ型インフルエンザウイルスの測定方法 |
| JP6262969B2 (ja) | 2013-09-10 | 2018-01-17 | デンカ生研株式会社 | Ａ型インフルエンザウイルスの測定方法 |
| US20160377616A1 (en) * | 2013-11-29 | 2016-12-29 | Sekisui Medical Co., Ltd. | Immunochromatographic detection method |
| JP6985572B2 (ja) * | 2015-11-09 | 2021-12-22 | 国立大学法人京都工芸繊維大学 | 単鎖抗体のスクリーニング方法及び単鎖抗体 |
| JP7065338B2 (ja) * | 2017-09-12 | 2022-05-12 | パナソニックＩｐマネジメント株式会社 | インフルエンザウイルス核内蛋白質に結合する抗体、複合体、それを用いた検出装置及び検出方法 |
| CN114276440B (zh) * | 2020-09-27 | 2022-12-27 | 东莞市朋志生物科技有限公司 | 针对乙型流感病毒的抗体和检测试剂盒 |
| CN114276441B (zh) * | 2020-09-27 | 2022-12-27 | 东莞市朋志生物科技有限公司 | 抗乙型流感病毒的抗体及其制备方法和检测试剂盒 |
| CN117384279A (zh) * | 2022-07-05 | 2024-01-12 | 东莞市朋志生物科技有限公司 | 抗乙型流感病毒抗体、检测乙型流感病毒的试剂和试剂盒 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10300750A (ja) * | 1997-04-23 | 1998-11-13 | Fujirebio Inc | 酵素免疫測定方法及び試験片 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2518607B2 (ja) * | 1985-08-29 | 1996-07-24 | 雪印乳業株式会社 | インフルエンザａ型ウイルスｈａ抗原に対するモノクロ―ナル抗体およびその作成方法 |
-
2004
- 2004-07-23 CN CNB2004800211308A patent/CN100441597C/zh not_active Expired - Fee Related
- 2004-07-23 KR KR1020067001431A patent/KR20060054333A/ko not_active Application Discontinuation
- 2004-07-23 WO PCT/JP2004/010476 patent/WO2005007698A1/ja active Application Filing
- 2004-07-23 RU RU2006103302/13A patent/RU2366663C2/ru not_active IP Right Cessation
- 2004-07-23 JP JP2005511914A patent/JPWO2005007698A1/ja active Pending
-
2007
- 2007-02-12 HK HK07101652.0A patent/HK1096975A1/xx unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10300750A (ja) * | 1997-04-23 | 1998-11-13 | Fujirebio Inc | 酵素免疫測定方法及び試験片 |
Non-Patent Citations (6)
| Title |
|---|
| B) no Kento. Masataka ICHIKAWA et al.The Journal of Medicine,Vol.49 No.3. 2003 * |
| Immuno chromatography-ho to Koso Men'sekiho oKumiawaseta Genri ni yoru Atarashii Influenza Jinsoku ShidanKit(Espline Influenza A & B) no Kento. Masataka ICHIKAWA et al.The Journal of Medicine,Vol.49 No.3. 2003 |
| Immuno chromatography-ho to Koso Men'sekiho oKumiawaseta Genri ni yoru Atarashii Influenza Jinsoku ShidanKit(Espline Influenza A & B) no Kento. Masataka ICHIKAWA et al.The Journal of Medicine,Vol.49 No.3. 2003 * |
| Immuno chromatography-ho to Koso Men'sekiho oKumiawaseta Genri ni yoru Atarashii Influenza Jinsoku ShidanKit(Espline Influenza A & * |
| Rapid detection and identification of two lineages of influenzaB strains with monoclonal antibodies. NAKAGAWA N. et al.J.Virological Methods,Vol.79 . 1999 |
| Rapid detection and identification of two lineages of influenzaB strains with monoclonal antibodies. NAKAGAWA N. et al.J.Virological Methods,Vol.79. 1999 * |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1096975A1 (en) | 2007-06-15 |
| CN1826355A (zh) | 2006-08-30 |
| JPWO2005007698A1 (ja) | 2008-01-17 |
| RU2006103302A (ru) | 2007-09-10 |
| RU2366663C2 (ru) | 2009-09-10 |
| KR20060054333A (ko) | 2006-05-22 |
| WO2005007698A1 (ja) | 2005-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1934133B (zh) | 抗a型流感病毒单克隆抗体及使用该抗体的免疫测定器具 | |
| CN100441597C (zh) | 抗b型流感病毒单克隆抗体及使用该抗体的免疫测定器具 | |
| EP1193499B1 (en) | Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device | |
| CN104849251B (zh) | 一种快速检测地沟油的时间分辨荧光免疫方法及试剂盒 | |
| CN109374907B (zh) | 一种黏菌素胶体金检测试剂盒及其应用 | |
| JP5010374B2 (ja) | 免疫測定装置用の対照系としてのウシアルブミンｐ−アミノフェニルＮ−アセチルβ−Ｄグルコサミニドの使用 | |
| JP2021531763A (ja) | 細菌性膣炎の診断 | |
| CN109374887A (zh) | 牛病毒性腹泻病毒抗原胶体金检测试剂盒及其应用 | |
| JP4976068B2 (ja) | 簡易イムノアッセイ用検体浮遊液およびアッセイ方法 | |
| KR20110096940A (ko) | 신속 면역크로마토그라피법을 이용한 신종 인플루엔자 진단 키트 | |
| CN105759030B (zh) | 一种检测弓形虫抗体的胶体金试纸条 | |
| CN110320364A (zh) | 一种双抗夹心胶体金检测试剂盒、及其制备方法与应用 | |
| CN109374886A (zh) | 牛传染性鼻气管炎病毒抗体检测试剂盒及其应用 | |
| CN110133256A (zh) | 一种通用性免疫层析试纸 | |
| US5225322A (en) | Immunoassays for detection of viral subtypes and other antigens | |
| JP2888526B2 (ja) | 抗体のサンドイッチイムノアッセイ法 | |
| CN108957002A (zh) | 具有双抗原夹心和双检测线的猪瘟病毒抗体定量检测试纸卡 | |
| CN102936584A (zh) | 氨基脲衍生物的单克隆抗体及其应用 | |
| CN102621319B (zh) | 鉴别经典prrs和hprrs的胶体金快速诊断试纸条 | |
| CN105974127A (zh) | 一种基于酶联免疫吸附技术的人中性粒细胞载脂蛋白异源二聚体定量装置 | |
| EP0152254A2 (en) | Chromogenic support immunoassay utilizing labeled complement components | |
| CN114829935A (zh) | 免疫测定方法及免疫测定工具 | |
| CN201637746U (zh) | 检测庆大霉素的免疫胶体金试剂板 | |
| KR101741206B1 (ko) | 유럽형 돼지생식기호흡기증후군 바이러스 특이항체 진단용 래피드 키트 | |
| CN206002549U (zh) | 一种基于酶联免疫吸附技术的人中性粒细胞载脂蛋白异源二聚体定量装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1096975 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1096975 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081210 Termination date: 20140723 |
|
| EXPY | Termination of patent right or utility model |